StonvexLoading…
StonvexStonvexStonvexCore line items from LNTH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.54B | $1.53B | $1.30B | $935.06M |
Operating Income | $310.83M | $456.98M | $364.64M | $36.20M |
Net Income | $233.56M | $312.44M | $326.66M | $28.07M |
EPS (Diluted) | $3.41 | $4.36 | $4.65 | $0.40 |
Total Assets | $2.23B | $1.98B | $1.65B | $1.32B |
Total Liabilities | $1.14B | $892.33M | $835.26M | $874.11M |
Cash & Equivalents | $359.12M | $912.81M | $713.66M | $415.65M |
Free Cash Flow OCF − CapEx | $354.05M | $493.13M | $258.70M | $263.43M |
Shares Outstanding | 64.59M | 68.45M | 69.86M | 68.85M |